MYC and pancreatic neoplasm: As it relates to pancreatic cancer, the disease focus of the current study, c‐MYC was found to be originally amplified in more than 30% of PDAC (Schleger et al, 2002) by using interphase fluorescence in situ hybridization, as well as overexpressed in more than 40% of tumors (Schleger et al, 2002).